Report Highlights
The report provides an overview of the intraocular lens (IOL) global market and analyses market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period from 2022 to 2027. Revenue forecasts for this period is segmented based on product type, material, indication and geography. It also highlights major trends and challenges that affect the market and the vendor landscape.
Report Includes
- 21 data tables and 2 additional tables
- A brief general outlook of the global market for intraocular lens (IOLs) within the medical devices industry
- Analyses of the global market trends, with market revenue data for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of key market potential for intraocular lens, technological trends, opportunities, and gaps estimating the current and future demand for IOLs market demand over the analysis period
- Estimation of the actual market size and revenue forecast for global intraocular lens market in USD million values, and corresponding market share analysis based on product type, age group, disease indication, and region
- In-depth analysis for each of the market segments based on the product type such as monofocal lens, multifocal lens, toric lens, and extended depth of focus (EDOF) lens across key geographies
- Information pertaining to strategic profiling of key companies (manufacturers and distributors) present across the globe and their competitive landscape, product launch strategies, and financial outlook
- Company profiles of major players within the industry, including Alcon, Bausch + Lomb, Hoya Corp., and Johnson & Johnson
Report Scope
In this report, the market has been segmented based on organization size, component, provider, type, industry and geography. The report provides an overview of the intraocular lens (IOL) global market and analyses market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period from 2022 to 2027. Revenue forecasts for this period are segmented based on product type, material, indication and geography. Market values have been estimated based on the total revenue of IOL solution providers.
The report covers the market for IOL with regard to the product type across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for IOL in 2021 and provides projections for the expected market size through 2027.
The regional market analysis of IOL devices is also covered in this report. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific and Rest of World regions. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Italy, France, Japan, China, India, Brazil, Mexico, GCC countries) will be covered within the regional segment. For market estimates, data are provided for 2020 because of the base year 2021, with estimates for 2022 and forecast value for 2027.
The scope of the study includes IOL devices and accessories that have been medically accepted and approved in the market, as well as sleep devices, which have been excluded from the study.
Report Synopsis
Report Metrics | Details | ||||||||
---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||
Forecast period considered | 2022-2027 | ||||||||
Base year market size | $2.4 billion | ||||||||
Market size forecast | $4.6 billion | ||||||||
Growth rate | CAGR of 11.3% for the forecast period of 2022-2027 | ||||||||
Units considered | $ Millions | ||||||||
Segments covered | Product Type, Indication, Material, Region | ||||||||
Key Market Drivers |
|
||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
- Rise in Geriatric Population and Vision Disorders
- Rise in Volume of Cataract Surgeries
- Molecular Medicine and Minimally Invasive Techniques.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Vision Care: Global Markets
The global market for vision care should grow from $63.1 billion in 2020 to $77.5 billion by 2025 at a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2020-2025.
Global Markets for Implantable Biomaterials
The global market for implantable biomaterials in 2013 was worth nearly $75.1 billion. This market is expected to grow at a compound annual growth rate (CAGR) of 6.7% between 2014 and 2019. This will result in $79.1 billion in 2014 and $109.5 billion global market in 2019.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More